Obalon Therapeutics, Inc. (OBLN) |
| 3.05 -0.19 (-5.86%) 06-16 00:00 |
| Open: | 3.25 |
| High: | 4.8 |
| Low: | 2.948 |
| Volume: | 26,469,075 |
| Market Cap: | 5(M) |
| PE Ratio: | -2.22 |
| Exchange: | NASDAQ Global Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 4.88 |
| Resistance 1: | 3.88 |
| Pivot price: | 3.26 |
| Support 1: | 2.26 |
| Support 2: | 1.88 |
| 52w High: | 32.31003 |
| 52w Low: | 1.980001 |
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.
| EPS | -1.594 |
| Book Value | 0.600 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.053 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -711.27 |
| Return on Assets (ttm) | -45.5 |
| Return on Equity (ttm) | -120.3 |
Mon, 03 Nov 2025
TELA Bio Appoints William Plovanic to Board of Directors - The Globe and Mail
Mon, 13 Jan 2025
ReShape Lifesciences® Provides Update on Merger Agreement - GlobeNewswire
Fri, 01 Dec 2023
ReShape and Obalon Merge in All-Stock Transaction - Medical Device and Diagnostic industry
Wed, 12 May 2021
About Us - FinancialContent
Wed, 20 Jan 2021
Obalon Therapeutics’ stock skyrockets after announcing ReShape Lifesciences merger - MassDevice
Thu, 13 Oct 2016
Obalon Therapeutics (OBLN) Stock Price, News & Analysis - MarketBeat
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |